Latest News

New clinical trial to test drug combination to treat osteogenesis imperfecta

The University of Edinburgh will conduct a six-year trial of teriparatide and zoledronic acid combination to treat a condition called osteogenesis imperfecta (OI). ...

New clinical trial to test drug combination to treat osteogenesis imperfecta

Allergan and Gedeon Richter report positive results from Venus II trial of ulipristal acetate

Allergan and Gedeon Richter have reported positive results from Venus II, the second of two pivotal phase III clinical trials evaluating the efficacy and safety of ulipristal acetate in women...

Allergan and Gedeon Richter report positive results from Venus II trial of ulipristal acetate

Jazz Pharmaceuticals begins enrolment in Phase III trial of defitelio to treat VOD

Jazz Pharmaceuticals begins enrolment in Phase III trial of defitelio to treat VOD

Clinical study suggests efficacy of modafinil to improve memory in patients with depression

Clinical study suggests efficacy of modafinil to improve memory in patients with depression

BioLineRx begins Phase IIa trial of BL-8040 combined with KEYTRUDA to treat metastatic pancreatic cancer

Clinical-stage bio-pharmaceutical company BioLineRx has begun its second Phase 2a trial investigating BL-8040 in combination with KEYTRUDA (pembrolizumab), MSD's anti-PD-1 therapy, in...

BioLineRx begins Phase IIa trial of BL-8040 combined with KEYTRUDA to treat metastatic pancreatic cancer

Chi-Med initiates Phase II study of sulfatinib to treat second-line biliary tract cancer in China

Chi-Med initiates Phase II study of sulfatinib to treat second-line biliary tract cancer in China

Tocagen commences Phase 2/3 clinical trial for recurrent brain cancer in South Korea

Tocagen commences Phase 2/3 clinical trial for recurrent brain cancer in South Korea

Pluristem closes enrolment for Phase II trial of PLX-PAD cells to treat intermittent claudication

Israeli-based drug development company Pluristem Therapeutics has closed enrolment for its Phase II trial of placental expanded (PLX-PAD) cells to treat intermittent claudication (IC), a...

Pluristem closes enrolment for Phase II trial of PLX-PAD cells to treat intermittent claudication

Sunovion reports results from Phase II/III (SEP360-221) study of dasotraline to treat BED

US-based biopharmaceutical company Sunovion has reported results from its Phase II/III (SEP360-221) study of dasotraline to treat moderate-to-severe binge eating disorder...

Sunovion reports results from Phase II/III (SEP360-221) study of dasotraline to treat BED

M&As this week: Allergan, Roche Holdings, Pharmaron

Irish pharmaceutical company Allergan has entered an option agreement with the shareholders of US-based Lysosomal Therapeutics (LTI), giving the former the right to acquire the...

M&As this week: Allergan, Roche Holdings, Pharmaron

Sanaria reports positive results from Phase II trial of PfSPZ Vaccine for malaria

Sanaria reports positive results from Phase II trial of PfSPZ Vaccine for malaria

Deals this week: Zebra Biologics, Mount Tam Biotechnologies, Adynxx

Zebra Biologics and AbbVie have signed an agreement to jointly discover agonist antibody therapeutics for inflammatory diseases using the former’s function-based antibody discovery...

Deals this week: Zebra Biologics, Mount Tam Biotechnologies, Adynxx

MorphoSys partner to initiate Phase II trial of bimagrumab to treat obese patients with type 2 diabetes

German biotechnology company MorphoSys' partner Novartis is set to begin its Phase II clinical trial of bimagrumab to treat obese patients with type 2...

MorphoSys partner to initiate Phase II trial of bimagrumab to treat obese patients with type 2 diabetes

Visterra begins Phase IIa trial of VIS410 to treat hospitalised patients with influenza A

US-based clinical-stage biopharmaceutical company Visterra has commenced its Phase IIa clinical trial of VIS410 to treat hospitalised patients with influenza...

Visterra begins Phase IIa trial of VIS410 to treat hospitalised patients with influenza A

TapImmune launches Phase II study of TPIV 200 to treat platinum-sensitive ovarian cancer

TapImmune launches Phase II study of TPIV 200 to treat platinum-sensitive ovarian cancer

Study finds antidepressant use increases hip fracture risk among patients with Alzheimer’s disease

The findings of a study conducted by the University of Eastern Finland suggested that antidepressant usage increases the risk of hip fracture in patients with Alzheimer’s disease residing in...

Study finds antidepressant use increases hip fracture risk among patients with Alzheimer’s disease

Ablynx initiates Phase IIb RESPIRE study of ALX-0171 to treat RSV infection

Ablynx initiates Phase IIb RESPIRE study of ALX-0171 to treat RSV infection

ThromboGenics begins patient enrolment for Phase II trial of THR-317 to treat diabetic macular edema

ThromboGenics begins patient enrolment for Phase II trial of THR-317 to treat diabetic macular edema

Research finds efficacy of anti-malaria drug to treat metastatic cancers

Research finds efficacy of anti-malaria drug to treat metastatic cancers

NeuroGenetic reports positive results from Phase I trials of NGP 555 to treat Alzheimer’s disease

US-based bio-pharmaceutical company NeuroGenetic has reported positive results from its Phase I clinical trials of NGP 555 to treat Alzheimer’s...

NeuroGenetic reports positive results from Phase I trials of NGP 555 to treat Alzheimer’s disease

Menlo Therapeutics begins patient enrolment for two Phase ll trials of serlopitant

US-based clinical stage pharmaceutical company Menlo Therapeutics has begun enrolling patients for two new Phase ll trials of a novel neurokinin 1 (NK-1) receptor antagonist, serlopitant, to...

Menlo Therapeutics begins patient enrolment for two Phase ll trials of serlopitant